moneyheap
ALGN · Analysis updated Nov 10, 2026, 6:00 PM ET
Why is Align Technology Inc (ALGN) stock moving?
Align has rallied sharply in the last week. The stock closed at $174.26 on Nov 10, up about 15% from the $151.58 close on Nov 3, and reached a 30-day high of $177.04 on Nov 9. Volume rose with the move: 1.70M shares on Nov 4 and 2.39M on Nov 9, well above the roughly 0.6M to 1.2M daily range of late October. Two company actions drove the upside. A $270M accelerated share repurchase, signed Nov 5, uses part of the $600M still available under the April 2025 program and starts with about 1.44M shares delivered up front, which adds steady buying pressure. A global restructuring plan to cut headcount, announced alongside the Q3 numbers around Nov 9, points to possible cost savings. On the fundamentals, Q3 revenue of $1.015B and adjusted EPS of $2.80 beat estimates, but growth was only 1.9% year over year. The Q4 revenue guide of $1.00B to $1.02B sits below the $1.048B consensus, and Morgan Stanley's Equal-Weight rating carries a $175 target that the shares have now nearly reached. The CEO transition, with Jennifer Davis taking over on Dec 31, 2026, adds execution uncertainty. Price has run well ahead of the late-October base near $150 to $152, so the near-term outlook depends on whether the buyback and restructuring sustain demand above recent levels.
News behind the analysis
- Align Technology Reports Q3 2026 Financial Results and Announces Global RestructuringAlign reported a 1.9% year-over-year revenue increase to $1.01 billion for Q3 2026 and announced a global restructuring plan to reduce headcount.
- Align Technology Announces $270 Million Accelerated Stock Repurchase AgreementAlign entered an accelerated share repurchase with Goldman Sachs to buy back $270 million of common stock, with an initial delivery of about 1.44 million shares.
- Align Technology Announces $270M Accelerate Buyback PlanAlign announced the $270 million accelerated buyback, which draws on the $600 million still remaining under its April 2025 repurchase program.
- Morgan Stanley Maintains Equal-Weight on Align Technology, Lowers Price Target to $175Morgan Stanley kept an Equal-Weight rating and cut its price target to $175 after the quarter.
- Align Technology Issues Fourth Quarter 2026 Revenue GuidanceAlign guided Q4 2026 revenue to $1.00 billion to $1.02 billion, below the $1.048 billion consensus cited by Benzinga.
- Align Technology Reports Third Quarter 2026 Financial ResultsAlign reported Q3 2026 revenue of $1.015 billion and adjusted EPS of $2.80, both ahead of analyst expectations.
- Align Technology Announces CEO Succession PlanJennifer L. Davis, former CEO of Procter & Gamble's Global Healthcare business, will become President and CEO effective Dec 31, 2026, succeeding Joseph M. Hogan.
- Align Tech Q3 Adj. EPS $2.80 Beats $2.78 Estimate, Sales $1.015B Beat $1.005B EstimateQ3 adjusted EPS of $2.80 and sales of $1.015 billion both topped consensus, though the beat was narrow.
- Align Technology Sees Q4 Sales $1.000B-$1.020B vs $1.048B EstBenzinga reported that the Q4 sales outlook sits below the $1.048 billion analyst estimate.
About Align Technology Inc
Align Technology is a medical device company based in Tempe, Arizona. It makes Invisalign clear aligners, iTero intraoral scanners and exocad dental design software. Invisalign is the best-known clear aligner brand, and its scanners and software link it into the digital workflow of orthodontists and dentists around the world.
How it makes money
About 80–85% of revenue comes from Clear Aligners: Invisalign cases sold to orthodontists and general-practice dentists, who then treat adult, teen and child patients. Shipments ran at roughly 690,000 cases a quarter in 2026. The remaining roughly 15–20% comes from Imaging Systems and CAD/CAM Services, mainly sales and leases of iTero scanners plus exocad software and services. This segment fell year over year in 2026. Total revenue is about $1 billion per quarter (approximately $4 billion a year).
What usually moves ALGN
- Clear aligner case volumes and average selling prices
- Consumer spending on elective dental treatment
- Dentists' and orthodontists' spending on iTero scanners
- Foreign exchange rates and international growth
- Competition from lower-priced aligner makers